Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
27,701,130
-
Share change
-
+2,348,048
-
Total reported value
-
$1,375,766,252
-
Price per share
-
$49.84
-
Number of holders
-
59
-
Value change
-
+$119,175,898
-
Number of buys
-
49
-
Number of sells
-
12
Institutional Holders of FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) as of Q3 2020
As of 30 Sep 2020,
FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,701,130 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BAKER BROS. ADVISORS LP, Samsara BioCapital, LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, and Logos Global Management LP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.